Cyclopharm Ltd - Company Profile
Powered by 
All the sales intelligence you need on Cyclopharm Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Cyclopharm Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Cyclopharm Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in nuclear medicine. The company’s products include Technegas, an ultra-fine dispersion of technetium-labelled carbon used for the detection of pulmonary embolism. The company is evaluating Technegas in new indications including chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary hypertension, lung volume reduction and asthma. Cyclopharm operates a joint venture, Macquarie Medical Imaging, which provides diagnostic imaging services such as magnetic resonance imaging (MRI), computed tomography (CT), breast imaging, X-ray, ultrasound, dual-energy X-ray absorptiometry (DEXA), and positron emission tomography (PET) scanning. It harnesses its Ultralute technology, which extends the life of Molybdenum-99 generators. The company operates across Asia Pacific, Canada, Latin America, Europe and Germany. Cyclopharm is headquartered in New South Wales, Australia.
Headquarters
Australia
Address
Unit 4 / 1 The Crescent, Kingsgrove, Sydney, New South Wales, 2208
Telephone
61 2 95410411
No of Employees
109
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CYC (ASX)
Revenue (2024)
$20.8M
17.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-30.5%
(2024 vs 2023)
Market Cap*
$44.5M
Net Profit Margin (2024)
XYZ
-11.3%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Services | Brands |
|---|---|---|
| Technegas Devices: | Diagnostic Imaging Services | Ultralute |
| TechnegasPlus | Technegas | |
| Technegas System | ||
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In January, the company entered into an agreement with the Yale Translational Research Imaging Center (Y-TRIC) to install Technegas. |
| 2023 | Regulatory Approval | In October, the company received approval from the US FDA for the use of Technegas in the US. |
| 2023 | Acquisitions/Mergers/Takeovers | In April, the company acquired DuPharma ApS. |
Competitor Comparison
| Key Parameters | Cyclopharm Ltd | Telix Pharmaceuticals Ltd | SoftMedx Healthcare Limited | Optiscan Imaging Ltd | Kent Hospital |
|---|---|---|---|---|---|
| Headquarters | Australia | Australia | Hong Kong | Australia | United States of America |
| City | Sydney | Melbourne | Hong Kong City | Mulgrave | Warwick |
| State/Province | New South Wales | Victoria | - | Victoria | Rhode Island |
| No. of Employees | 109 | 1,120 | 20 | 8 | - |
| Entity Type | Public | Public | Public | Public | Institution |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James McBrayer | Managing Director; Secretary | Executive Board | 2011 | - |
| Mathew Farag | Chief Operating Officer | Senior Management | 2017 | - |
| Doug Cubbin | Chairman | Non Executive Board | 2026 | - |
| Dianne M. Angus | Director | Non Executive Board | 2021 | - |
| Kevin M. J. Barrow | Director | Non Executive Board | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer